Terms: = Liver cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809 AND Prognosis
247 results:
1. Investigation of prunetrin induced G2/M cell cycle arrest and apoptosis via Akt/mtor/MAPK pathways in hepatocellular carcinoma cells.
Abusaliya A; Bhosale PB; Kim HH; Park MY; Jeong SH; Lee S; Kim GS
Biomed Pharmacother; 2024 May; 174():116483. PubMed ID: 38552440
[TBL] [Abstract] [Full Text] [Related]
2. Metformin and pancreatic neuroendocrine tumors: A systematic review and meta-analysis.
Cigrovski Berkovic M; Coppola A; Sesa V; Mrzljak A; Lai Q
World J Gastroenterol; 2024 Feb; 30(7):759-769. PubMed ID: 38515954
[TBL] [Abstract] [Full Text] [Related]
3. Integrated clinical and prognostic analyses of mtor/Hippo pathway core genes in hepatocellular carcinoma.
Feng T; Chen P; Wang T; Lai C; Yao Y
J Physiol Biochem; 2024 May; 80(2):439-449. PubMed ID: 38468074
[TBL] [Abstract] [Full Text] [Related]
4. Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mtor signaling pathway in triple negative breast cancer.
Ou X; Tan Y; Xie J; Yuan J; Deng X; Shao R; Song C; Cao X; Xie X; He R; Li Y; Tang H
Drug Resist Updat; 2024 Mar; 73():101063. PubMed ID: 38335844
[TBL] [Abstract] [Full Text] [Related]
5. Mitochondrial ribosomal protein L12 potentiates hepatocellular carcinoma by regulating mitochondrial biogenesis and metabolic reprogramming.
Ji X; Yang Z; Li C; Zhu S; Zhang Y; Xue F; Sun S; Fu T; Ding C; Liu Y; Wan Q
Metabolism; 2024 Mar; 152():155761. PubMed ID: 38104924
[TBL] [Abstract] [Full Text] [Related]
6. FARSB Facilitates Hepatocellular Carcinoma Progression by Activating the mtorC1 Signaling Pathway.
Wang Y; Wang G; Hu S; Yin C; Zhao P; Zhou X; Shao S; Liu R; Hu W; Liu GL; Ke W; Song Z
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069034
[TBL] [Abstract] [Full Text] [Related]
7. NR0B1 augments sorafenib resistance in hepatocellular carcinoma through promoting autophagy and inhibiting apoptosis.
Tan XL; Wang Z; Liao S; Yi M; Tao D; Zhang X; Leng X; Shi J; Xie S; Yang Y; Liu YQ
Cancer Sci; 2024 Feb; 115(2):465-476. PubMed ID: 37991109
[TBL] [Abstract] [Full Text] [Related]
8. SRSF7 is a promising prognostic biomarker in hepatocellular carcinoma and is associated with immune infiltration.
Shen W; Yuan L; Cheng F; Wu Z; Li X
Genes Genomics; 2024 Jan; 46(1):49-64. PubMed ID: 37985547
[TBL] [Abstract] [Full Text] [Related]
9. SNHG15 promotes gallbladder cancer progression by enhancing the autophagy of tumor cell under nutrition stress.
Min H; Yang L; Xu X; Geng Y; Liu F; Liu Y
Cell Cycle; 2023 Oct; 22(19):2130-2141. PubMed ID: 37937948
[TBL] [Abstract] [Full Text] [Related]
10. Integrated analysis of histone lysine lactylation (Kla)-specific genes suggests that NR6A1, OSBP2 and UNC119B are novel therapeutic targets for hepatocellular carcinoma.
Wu Q; Li X; Long M; Xie X; Liu Q
Sci Rep; 2023 Oct; 13(1):18642. PubMed ID: 37903971
[TBL] [Abstract] [Full Text] [Related]
11. KDM6A promotes hepatocellular carcinoma progression and dictates lenvatinib efficacy by upregulating FGFR4 expression.
Guo W; Li S; Qian Y; Li L; Wang F; Tong Y; Li Q; Zhu Z; Gao WQ; Liu Y
Clin Transl Med; 2023 Oct; 13(10):e1452. PubMed ID: 37846441
[TBL] [Abstract] [Full Text] [Related]
12. Case Report: Complete pathological remission of human chorionic gonadotrophin-producing gallbladder carcinoma with multiple liver metastases after treatment with chemotherapy plus an immune checkpoint inhibitor.
Wang Q; Mu Y; Ji S; Liu Y; Lou Y; Wei S; Dong X; Zhang B
Front Immunol; 2023; 14():1173520. PubMed ID: 37841278
[TBL] [Abstract] [Full Text] [Related]
13. Clinical implications of RAB13 expression in pan-cancer based on multi-databases integrative analysis.
Zhang XD; Liu ZY; Luo K; Wang XK; Wang MS; Huang S; Li RF
Sci Rep; 2023 Oct; 13(1):16859. PubMed ID: 37803063
[TBL] [Abstract] [Full Text] [Related]
14. The m
Ma E; Li J; Shen C; Gu Y; Zhang X; Li L; Zhao J; Wang Z
Front Immunol; 2023; 14():1227593. PubMed ID: 37691948
[TBL] [Abstract] [Full Text] [Related]
15. Integrative analysis reveals that SLC38A1 promotes hepatocellular carcinoma development via PI3K/AKT/mtor signaling via glutamine mediated energy metabolism.
Feng HG; Wu CX; Zhong GC; Gong JP; Miao CM; Xiong B
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15879-15898. PubMed ID: 37673823
[TBL] [Abstract] [Full Text] [Related]
16. PRL2 inhibition elevates PTEN protein and ameliorates progression of acute myeloid leukemia.
Carlock C; Bai Y; Paige-Hood A; Li Q; Nguele Meke F; Zhang ZY
JCI Insight; 2023 Oct; 8(19):. PubMed ID: 37665633
[TBL] [Abstract] [Full Text] [Related]
17. Mechanistic Action of Cell Cycle Arrest and Intrinsic Apoptosis via Inhibiting Akt/mtor and Activation of p38-MAPK Signaling Pathways in Hep3B liver cancer Cells by Prunetrin-A Flavonoid with Therapeutic Potential.
Abusaliya A; Jeong SH; Bhosale PB; Kim HH; Park MY; Kim E; Won CK; Park KI; Heo JD; Kim HW; Ahn M; Seong JK; Kim GS
Nutrients; 2023 Jul; 15(15):. PubMed ID: 37571343
[TBL] [Abstract] [Full Text] [Related]
18. High expression of ENPP2 is an independent predictor of poor prognosis in liver cancer.
Meng J; Ruan X; Wei F; Xue Q
Medicine (Baltimore); 2023 Aug; 102(31):e34480. PubMed ID: 37543832
[TBL] [Abstract] [Full Text] [Related]
19. Inetetamab in combination with rapamycin and chemotherapy for trastuzumab-treated metastatic human epidermal growth factor receptor 2-positive breast cancer with abnormal activation of PI3K/Akt/mtor pathway.
Wang A; Li C; Jiang Q; Jiang S
Cancer Rep (Hoboken); 2023 Sep; 6(9):e1864. PubMed ID: 37501598
[TBL] [Abstract] [Full Text] [Related]
20. Pharmaco-proteogenomic characterization of liver cancer organoids for precision oncology.
Ji S; Feng L; Fu Z; Wu G; Wu Y; Lin Y; Lu D; Song Y; Cui P; Yang Z; Sang C; Song G; Cai S; Li Y; Lin H; Zhang S; Wang X; Qiu S; Zhang X; Hua G; Li J; Zhou J; Dai Z; Wang X; Ding L; Wang P; Gao D; Zhang B; Rodriguez H; Fan J; Clevers H; Zhou H; Sun Y; Gao Q
Sci Transl Med; 2023 Jul; 15(706):eadg3358. PubMed ID: 37494474
[TBL] [Abstract] [Full Text] [Related]
[Next]
